ACE2 and COVID-19 Susceptibility and Severity

Area of Science:

• Virology
• Genetics
• Immunology

Background:

• Certain demographics, including males and older individuals, face higher COVID-19 risks.
• The underlying biological mechanisms linking demographics to COVID-19 vulnerability are not fully understood.
• Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) utilizes the angiotensin-converting enzyme 2 (ACE2) receptor for cellular entry.

Purpose of the Study:

• To investigate the role of pulmonary ACE2 expression in COVID-19 demographic disparities.
• To determine the causal relationship between ACE2 and COVID-19 susceptibility and severity using Mendelian randomization.
• To compare the cellular tropism of SARS-CoV-2 with other respiratory viruses.

Main Methods:

• Analysis of demographic data related to pulmonary ACE2 expression.
• Mendelian randomization (MR) integrating genome-wide association studies (GWAS) and cis-expression quantitative trait loci (cis-eQTLs) for ACE2.
• Single-cell RNA sequencing (scRNA-seq) to analyze host cell receptor expression and viral tropism in human lung tissues.

Main Results:

• Distinct subphenotypes in pulmonary ACE2 expression correlate with demographic vulnerabilities in COVID-19.
• MR analysis confirmed a causal role of ACE2 in COVID-19 susceptibility and severity.
• SARS-CoV-2 shares overlapping cellular tropism with other respiratory viruses, particularly in alveolar type 2 (AT2) cells.
• Comparative tropism analysis suggests natural selection pressures on viral entry mechanisms.

Conclusions:

• ACE2 plays a significant role in COVID-19 vulnerability across different demographics, presenting a potential therapeutic target.
• The shared tropism in AT2 cells highlights the potential for coinfection with other respiratory viruses.
• Comparative tropism analysis offers insights into viral evolution and zoonotic spillover events.